GD vs XBIO · P/E 22, rev $52.55B vs rev $1.5M
General Dynamics Corporation (GD) versus Xenetic Biosciences Inc (XBIO) — a side-by-side from cached financials, not a winner call.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Xenetic Biosciences Inc (XBIO) is a biotechnology company listed on US.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Latest reported XBIO revenue for 2026-06-30 was $1.5M. Net income was -$1.4M. Revenue was up 81.9% from 2026-03-31 to 2026-06-30. XBIO currently screens at market cap $5.7M.
GD currently screens at market cap $93.69B and trailing P/E 21.8. XBIO currently screens at market cap $5.7M.
Not investment advice. Open the GD and XBIO stock pages for the full models.
Not investment advice.